| Description | 2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine (2-[(1E)-(dibenzylhydrazin-1-ylidene)methyl]pyridine) is a heterocyclic compound. It inhibits monoamine oxidase, resulting in elevated monoamine levels in the body. It can also inhibit adenosine deaminase, resulting in elevated levels of adenosine in the body. It can also increase the activity of certain neurotransmitters, including serotonin and dopamine. |
| Target activity | G6Pase catalytic subunit 1 (human):10µM |
| Synonyms | 2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine, 2-[(1E)-(dibenzylhydrazin-1-ylidene)methyl]pyridine |
| molecular weight | 301.39 |
| Molecular formula | C20H19N3 |
| CAS | 237402-29-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: 50 mg/mL (165.9 mM) |
G6Pase catalytic subunit 1 inhibitor 1
CAS No.: 237402-29-8
2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine (2-[(1E)-(dibenzylhydrazin-1-ylidene)methyl]pyridine) is a heterocyclic
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.